Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

Safety and effectiveness of oral factor Xa inhibitors versus warfarin in nonvalvular atrial fibrillation patients at high-risk for falls.

Miao B, Alberts MJ, Bunz TJ, Coleman CI.

J Thromb Thrombolysis. 2019 Oct;48(3):366-372. doi: 10.1007/s11239-019-01898-7.

PMID:
31228038
2.

Cost and inpatient burden of peripheral artery disease: Findings from the National Inpatient Sample.

Kohn CG, Alberts MJ, Peacock WF, Bunz TJ, Coleman CI.

Atherosclerosis. 2019 Jul;286:142-146. doi: 10.1016/j.atherosclerosis.2019.05.026. Epub 2019 May 27.

PMID:
31170647
3.

Recommendations for the Establishment of Stroke Systems of Care: A 2019 Update.

Adeoye O, Nyström KV, Yavagal DR, Luciano J, Nogueira RG, Zorowitz RD, Khalessi AA, Bushnell C, Barsan WG, Panagos P, Alberts MJ, Tiner AC, Schwamm LH, Jauch EC.

Stroke. 2019 Jul;50(7):e187-e210. doi: 10.1161/STR.0000000000000173. Epub 2019 May 20.

PMID:
31104615
4.

Dawn of a New Era for Stroke Treatment: Implications of the DAWN Study for Acute Stroke Care and Stroke Systems of Care.

Alberts MJ, Ollenschleger MD, Nouh A.

Circulation. 2018 Apr 24;137(17):1767-1769. doi: 10.1161/CIRCULATIONAHA.118.033579. Epub 2018 Jan 18. No abstract available.

PMID:
29348262
5.

Adding patent foramen ovale closure to antiplatelet drugs reduced ischemic stroke after cryptogenic stroke.

Alberts MJ.

Ann Intern Med. 2018 Jan 16;168(2):JC6. doi: 10.7326/ACPJC-2018-168-2-006. No abstract available.

PMID:
29335718
6.

Piloting a Sex-Specific, Technology-Enhanced, Active Learning Intervention for Stroke Prevention in Women.

Dirickson A, Stutzman SE, Alberts MJ, Novakovic RL, Stowe AM, Beal CC, Goldberg MP, Olson DM.

J Neurosci Nurs. 2017 Dec;49(6):349-354. doi: 10.1097/JNN.0000000000000323.

PMID:
29117030
7.

Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.

Coleman CI, Peacock WF, Bunz TJ, Alberts MJ.

Stroke. 2017 Aug;48(8):2142-2149. doi: 10.1161/STROKEAHA.117.017474. Epub 2017 Jun 27.

PMID:
28655814
8.

Stroke Treatment With Intravenous Tissue-Type Plasminogen Activator: More Proof That Time Is Brain.

Alberts MJ.

Circulation. 2017 Jan 10;135(2):140-142. doi: 10.1161/CIRCULATIONAHA.116.025724. No abstract available.

PMID:
28069710
9.

Availability of endovascular therapies for cerebrovascular disease at primary stroke centers.

Alberts MJ, Range J, Spencer W, Cantwell V, Hampel MJ.

Interv Neuroradiol. 2017 Feb;23(1):64-68. doi: 10.1177/1591019916678199. Epub 2016 Nov 30.

10.

Prehospital care delivery and triage of stroke with emergent large vessel occlusion (ELVO): report of the Standards and Guidelines Committee of the Society of Neurointerventional Surgery.

Pride GL, Fraser JF, Gupta R, Alberts MJ, Rutledge JN, Fowler R, Ansari SA, Abruzzo T, Albani B, Arthur A, Baxter B, Bulsara KR, Chen M, Delgado Almandoz JE, Gandhi CD, Heck D, Hetts SW, Hirsch JA, Hussain MS, Klucznik R, Lee SK, Mack WJ, Leslie-Mazwi T, McTaggart RA, Meyers PM, Mocco J, Prestigiacomo C, Patsalides A, Rasmussen P, Starke RM, Sunenshine P, Frei D, Jayaraman MV; Standards and Guidelines Committee of the Society of NeuroInterventional Surgery (SNIS).

J Neurointerv Surg. 2017 Aug;9(8):802-812. doi: 10.1136/neurintsurg-2016-012699. Epub 2016 Oct 5. No abstract available.

PMID:
27707873
11.

Pooled RCTs: After ischemic stroke or TIA, aspirin for secondary prevention reduced early recurrence and severity.

Alberts MJ.

Ann Intern Med. 2016 Sep 20;165(6):JC27. doi: 10.7326/ACPJC-2016-165-6-027. No abstract available.

PMID:
27653724
12.

Association Between Serum Calcium Level and the Size and Expansion of Intracerebral Hemorrhage.

Alberts MJ, Sarode R.

JAMA Neurol. 2016 Nov 1;73(11):1276-1277. doi: 10.1001/jamaneurol.2016.3070. No abstract available.

PMID:
27598439
13.

Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke.

Alberts MJ, Peacock WF, Fields LE, Bunz TJ, Nguyen E, Milentijevic D, Schein JR, Coleman CI.

Int J Cardiol. 2016 Jul 15;215:11-3. doi: 10.1016/j.ijcard.2016.03.212. Epub 2016 Apr 4. No abstract available.

PMID:
27104919
14.

Evidence-Based Policy Making: Assessment of the American Heart Association's Strategic Policy Portfolio: A Policy Statement From the American Heart Association.

Labarthe DR, Goldstein LB, Antman EM, Arnett DK, Fonarow GC, Alberts MJ, Hayman LL, Khera A, Sallis JF, Daniels SR, Sacco RL, Li S, Ku L, Lantz PM, Robinson JG, Creager MA, Van Horn L, Kris-Etherton P, Bhatnagar A, Whitsel LP; American Heart Association Advocacy Coordinating Committee, Council on Hypertension, Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Council on Quality of Care and Outcomes Research, Council on Cardiovascular Surgery and Anesthesia, Council on Functional Genomics and Translational Biology, and Council on Epidemiology and Prevention.

Circulation. 2016 May 3;133(18):e615-53. doi: 10.1161/CIR.0000000000000410. Epub 2016 Apr 4. Review.

PMID:
27045139
15.

Endovascular Therapy for Acute Ischemic Stroke: Dawn of a New Era.

Alberts MJ, Shang T, Magadan A.

JAMA Neurol. 2015 Oct;72(10):1101-3. doi: 10.1001/jamaneurol.2015.1743. No abstract available.

PMID:
26237199
16.

Combination therapy of intravenous glycoprotein IIB/IIIA inhibitors and tissue plasminogen activator for acute ischemic stroke.

Dubey D, Banerjee C, Sawhney A, Sharma A, Alberts MJ.

Neurol India. 2014 Nov-Dec;62(6):631-4. doi: 10.4103/0028-3886.149385.

17.

Carotid stenting—why treating an artery may not treat the patient.

Alberts MJ.

JAMA Neurol. 2015 Mar;72(3):263-4. doi: 10.1001/jamaneurol.2014.4142. No abstract available.

PMID:
25581841
18.

Efficacy and safety of novel oral anticoagulants in patients with cervical artery dissections.

Caprio FZ, Bernstein RA, Alberts MJ, Curran Y, Bergman D, Korutz AW, Syed F, Ansari SA, Prabhakaran S.

Cerebrovasc Dis. 2014;38(4):247-53. doi: 10.1159/000366265. Epub 2014 Nov 13.

PMID:
25401389
19.

Do primary stroke centers occur randomly?

Alberts MJ.

Stroke. 2014 Dec;45(12):3499-500. doi: 10.1161/STROKEAHA.114.007160. Epub 2014 Nov 11. No abstract available.

PMID:
25388422
20.

Diagnostic yield of pelvic magnetic resonance venography in patients with cryptogenic stroke and patent foramen ovale.

Liberman AL, Daruwalla VJ, Collins JD, Maas MB, Botelho MP, Ayache JB, Carr J, Ruff I, Bernstein RA, Alberts MJ, Prabhakaran S.

Stroke. 2014 Aug;45(8):2324-9. doi: 10.1161/STROKEAHA.114.005539. Epub 2014 Jun 17.

PMID:
24938843
21.

Stroke outcomes measures must be appropriately risk adjusted to ensure quality care of patients: a presidential advisory from the American Heart Association/American Stroke Association.

Fonarow GC, Alberts MJ, Broderick JP, Jauch EC, Kleindorfer DO, Saver JL, Solis P, Suter R, Schwamm LH.

Stroke. 2014 May;45(5):1589-601. doi: 10.1161/STR.0000000000000014. Epub 2014 Feb 12. Erratum in: Stroke. 2014 May;45(5):e96.

PMID:
24523036
22.

Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry.

Ruff CT, Bhatt DL, Steg PG, Gersh BJ, Alberts MJ, Hoffman EB, Ohman EM, Eagle KA, Lip GY, Goto S; REACH Registry Investigators.

Int J Cardiol. 2014 Jan 1;170(3):413-8. doi: 10.1016/j.ijcard.2013.11.030. Epub 2013 Nov 25.

PMID:
24321327
23.

NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.

Kohli P, Steg PG, Cannon CP, Smith SC Jr, Eagle KA, Ohman EM, Alberts MJ, Hoffman E, Guo J, Simon T, Sorbets E, Goto S, Bhatt DL; REACH Registry Investigators.

Am J Med. 2014 Jan;127(1):53-60.e1. doi: 10.1016/j.amjmed.2013.08.017. Epub 2013 Nov 23.

PMID:
24280110
24.

Formation and function of acute stroke-ready hospitals within a stroke system of care recommendations from the brain attack coalition.

Alberts MJ, Wechsler LR, Jensen ME, Latchaw RE, Crocco TJ, George MG, Baranski J, Bass RR, Ruff RL, Huang J, Mancini B, Gregory T, Gress D, Emr M, Warren M, Walker MD.

Stroke. 2013 Dec;44(12):3382-93. doi: 10.1161/STROKEAHA.113.002285. Epub 2013 Nov 12.

PMID:
24222046
25.

Interactions within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association.

Higashida R, Alberts MJ, Alexander DN, Crocco TJ, Demaerschalk BM, Derdeyn CP, Goldstein LB, Jauch EC, Mayer SA, Meltzer NM, Peterson ED, Rosenwasser RH, Saver JL, Schwamm L, Summers D, Wechsler L, Wood JP; American Heart Association Advocacy Coordinating Committee.

Stroke. 2013 Oct;44(10):2961-84. doi: 10.1161/STR.0b013e3182a6d2b2. Epub 2013 Aug 29. No abstract available.

PMID:
23988638
26.

Prehospital triage to primary stroke centers and rate of stroke thrombolysis.

Prabhakaran S, O'Neill K, Stein-Spencer L, Walter J, Alberts MJ.

JAMA Neurol. 2013 Sep 1;70(9):1126-32. doi: 10.1001/jamaneurol.2013.293.

PMID:
23817961
27.

Genetics of warfarin dosing--one polymorphism at a time.

Alberts MJ.

Lancet. 2013 Aug 31;382(9894):749-51. doi: 10.1016/S0140-6736(13)60942-3. Epub 2013 Jun 5. No abstract available.

PMID:
23755829
28.

Efficacy and safety of vorapaxar in patients with prior ischemic stroke.

Morrow DA, Alberts MJ, Mohr JP, Ameriso SF, Bonaca MP, Goto S, Hankey GJ, Murphy SA, Scirica BM, Braunwald E; Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events–TIMI 50 Steering Committee and Investigators.

Stroke. 2013 Mar;44(3):691-8. doi: 10.1161/STROKEAHA.111.000433. Epub 2013 Feb 8.

PMID:
23396280
29.

Leukoaraiosis on magnetic resonance imaging correlates with worse outcomes after spontaneous intracerebral hemorrhage.

Caprio FZ, Maas MB, Rosenberg NF, Kosteva AR, Bernstein RA, Alberts MJ, Prabhakaran S, Naidech AM.

Stroke. 2013 Mar;44(3):642-6. doi: 10.1161/STROKEAHA.112.676890. Epub 2013 Feb 7.

PMID:
23391853
30.

A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease.

Ducrocq G, Amarenco P, Labreuche J, Alberts MJ, Mas JL, Ohman EM, Goto S, Lavallée P, Bhatt DL, Steg PG.

Circulation. 2013 Feb 12;127(6):730-8. doi: 10.1161/CIRCULATIONAHA.112.141572. Epub 2012 Dec 31.

PMID:
23277306
31.

tPA and warfarin: time to move forward.

Alberts MJ, Naidech AM.

Neurology. 2013 Feb 5;80(6):514-5. doi: 10.1212/WNL.0b013e31827b1b7c. Epub 2012 Dec 5. No abstract available.

PMID:
23223535
32.

Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation.

Alberts MJ, Eikelboom JW, Hankey GJ.

Lancet Neurol. 2012 Dec;11(12):1066-81. doi: 10.1016/S1474-4422(12)70258-2. Review.

PMID:
23153406
33.

Improving public education about stroke.

Alberts MJ.

Ann N Y Acad Sci. 2012 Sep;1268:45-50. doi: 10.1111/j.1749-6632.2012.06722.x. Review.

PMID:
22994220
34.

ACP Journal Club. Citicoline did not improve recovery at 90 days after moderate-to-severe acute ischemic stroke.

Alberts MJ.

Ann Intern Med. 2012 Sep 18;157(6):JC3-13. doi: 10.7326/0003-4819-157-6-201209180-02013. No abstract available.

PMID:
22986405
35.

Antithrombotic therapy for secondary stroke prevention.

Alberts MJ.

Continuum (Minneap Minn). 2011 Dec;17(6 2ndary Stroke Prevention):1255-66. doi: 10.1212/01.CON.0000410034.19230.03.

PMID:
22810029
36.

Cerebral hemorrhage, warfarin, and intravenous tPA: the real risk is not treating.

Alberts MJ.

JAMA. 2012 Jun 27;307(24):2637-9. doi: 10.1001/jama.2012.7265. No abstract available.

PMID:
22735434
37.

An international model to predict recurrent cardiovascular disease.

Wilson PW, D'Agostino R Sr, Bhatt DL, Eagle K, Pencina MJ, Smith SC, Alberts MJ, Dallongeville J, Goto S, Hirsch AT, Liau CS, Ohman EM, Röther J, Reid C, Mas JL, Steg PG; REACH Registry.

Am J Med. 2012 Jul;125(7):695-703.e1. doi: 10.1016/j.amjmed.2012.01.014.

PMID:
22727237
38.

An evidence-based score to detect prevalent peripheral artery disease (PAD).

Duval S, Massaro JM, Jaff MR, Boden WE, Alberts MJ, Califf RM, Eagle KA, D'Agostino RB Sr, Pedley A, Fonarow GC, Murabito JM, Steg PG, Bhatt DL, Hirsch AT; REACH Registry Investigators.

Vasc Med. 2012 Oct;17(5):342-51. doi: 10.1177/1358863X12445102. Epub 2012 Jun 17.

PMID:
22711750
39.

Teaching neuroimages: locked-in syndrome resulting from traumatic basilar artery occlusion following clivus fracture.

Sen-Gupta I, Daiga DA, Alberts MJ.

Neurology. 2012 Jun 12;78(24):e148-9. doi: 10.1212/WNL.0b013e318259e237. No abstract available.

PMID:
22689739
40.

Letter by Bernstein et al regarding article, "reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.

Bernstein RA, Alberts MJ, Garcia DA.

Circulation. 2012 Apr 24;125(16):e614; author reply e616. doi: 10.1161/CIRCULATIONAHA.111.073668. No abstract available.

PMID:
22529072
41.

Prior anti-thrombotic drugs and stroke mortality.

Alberts MJ.

Heart. 2012 May;98(9):677-8. doi: 10.1136/heartjnl-2012-301726. No abstract available.

PMID:
22523051
42.

ACP Journal Club. Targeting management of fever, hyperglycemia, and swallowing improved outcomes in acute stroke.

Alberts MJ.

Ann Intern Med. 2012 Mar 20;156(6):JC3-9. doi: 10.7326/0003-4819-156-6-201203200-02009. No abstract available.

PMID:
22431695
43.

Using dabigatran in patients with stroke: a practical guide for clinicians.

Alberts MJ, Bernstein RA, Naccarelli GV, Garcia DA.

Stroke. 2012 Jan;43(1):271-9. doi: 10.1161/STROKEAHA.111.622498. Epub 2011 Dec 8. No abstract available.

PMID:
22156688
44.

Secondary preventive medication persistence and adherence 1 year after stroke.

Bushnell CD, Olson DM, Zhao X, Pan W, Zimmer LO, Goldstein LB, Alberts MJ, Fagan SC, Fonarow GC, Johnston SC, Kidwell C, Labresh KA, Ovbiagele B, Schwamm L, Peterson ED; AVAIL Investigators.

Neurology. 2011 Sep 20;77(12):1182-90. doi: 10.1212/WNL.0b013e31822f0423. Epub 2011 Sep 7.

45.

Two-year vascular event rates in patients with symptomatic cerebrovascular disease: the REACH registry.

Venketasubramanian N, Röther J, Bhatt DL, Pasquet B, Mas JL, Alberts MJ, Hill MD, Aichner F, Steg PG; REACH Investigators.

Cerebrovasc Dis. 2011;32(3):254-60. doi: 10.1159/000328650. Epub 2011 Aug 26.

PMID:
21876353
46.

Revised and updated recommendations for the establishment of primary stroke centers: a summary statement from the brain attack coalition.

Alberts MJ, Latchaw RE, Jagoda A, Wechsler LR, Crocco T, George MG, Connolly ES, Mancini B, Prudhomme S, Gress D, Jensen ME, Bass R, Ruff R, Foell K, Armonda RA, Emr M, Warren M, Baranski J, Walker MD; Brain Attack Coalition.

Stroke. 2011 Sep;42(9):2651-65. doi: 10.1161/STROKEAHA.111.615336. Epub 2011 Aug 25.

PMID:
21868727
47.

ACP Journal Club. Review: stenting increases stroke but decreases periprocedural MI compared with endarterectomy in carotid artery disease.

Alberts MJ.

Ann Intern Med. 2011 Aug 16;155(4):JC2-10. doi: 10.7326/0003-4819-155-4-201108160-02010. No abstract available.

PMID:
21844543
48.

Early platelet transfusion improves platelet activity and may improve outcomes after intracerebral hemorrhage.

Naidech AM, Liebling SM, Rosenberg NF, Lindholm PF, Bernstein RA, Batjer HH, Alberts MJ, Kwaan HC.

Neurocrit Care. 2012 Feb;16(1):82-7. doi: 10.1007/s12028-011-9619-3.

49.

Risk factors and outcomes for patients with vascular disease and serious bleeding events.

Alberts MJ, Bhatt DL, Smith SC Jr, Röther J, Goto S, Hirsch AT, Steg PG; REACH Registry Investigators.

Heart. 2011 Sep;97(18):1507-12. doi: 10.1136/hrt.2010.221788. Epub 2011 Jun 29.

PMID:
21715441
50.

Endovascular stroke therapy: a single-center retrospective review.

Day JS, Hurley MC, Chmayssani M, Rahme RJ, Alberts MJ, Bernstein RA, Dabus G, Shaibani A, Bendok BR.

Neurosurg Focus. 2011 Jun;30(6):E10. doi: 10.3171/2011.3.FOCUS10267.

PMID:
21631211

Supplemental Content

Loading ...
Support Center